This is the worst the GLP drugs will ever be The smartest person I know in medicine, Dave Park, has told me the only reason surgeons ever have something to do is because medicine hasnt figured out how to solve the problem yet. And in that spirit, todays newsletter is about celebrating the advances in the field of the GLP drugs, which are solving a problem I didnt think medicine would ever solve: curing obesity and metabolic syndrome in our modern food and movement environment
Decades of research have demonstrated that the brain integrates hormonal, metabolic, cognitive and emotional signals to maintain energy balance, and dysregulation of these neural circuits can lead to conditions such as obesity or eating disorders 1,2
"People who really believe that that's the power of placebo." B12 has me like —@katyperry As a geriatrician at Mount Sinai Hospital in Toronto, Sinha said he commonly tests for B12 levels in patients "when we're assessing a person for dementia or a person with balance issues." Otherwise he said it's ineffective to take B12 supplements to prevent deficiency and there are even potential risks of over-doing it
Addressing the risk of ocular complications of GLP-1RAs
For many 5 mg or 10 mg research vials, 1 mL to 2 mL is a common calculator range because it keeps syringe measurements readable
When sex emerged as a significant factor, separate ANOVAs were performed for males and females